Tag Archives: IDSA

The Ad Hoc Patient and Physician Coalition From Around the World Reject Newly Proposed IDSA Guidelines

The Ad Hoc Patient and Physician Coalition Comments of the IDSA Proposed Lyme Guidelines “About the Ad Hoc Patient and Physician Coalition: The Ad Hoc Patient and Physician Coalition consists of patients and physicians who are concerned that the proposed Lyme disease guidelines of the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Continues →

The new draft of the Infectious Disease Society of America (IDSA) guidelines open for public comment for 45 days.

The IDSA has presented their draft guidelines which with a brief scan appear not much different then their old controversial poorly evidenced guidelines.  Much of the same old players and 3 token patients. Typical unequal representation. Public comments close August 10th. Take your time, make notes before you enter their controlled comment format process as you have to submit all Continues →

Congress Acts to Improve CDC and NIH Lyme Disease Programs [Canada Fails]

Tuesday, April 10, 2018 [CanLyme Note: The Canadian system via the Pubic Health Agency of Canada (PHAC) and the Canadian Institute of Health Research (CIHR) adopted the same corrupted, biased position of the US CDC.  Now we need Canadian parliamentarians to do the right thing for the sick. Last year, Health Canada announced there would be a tiny bit of Continues →

Lawsuit: Insurance companies conspiring with physician members of the Infectious Diseases Society of America

November 19th, 2017 Lynne LaRowe Texackana Gazette Major health insurance companies are accused of putting profits over patients suffering from Lyme disease in a lawsuit filed recently in a Texarkana, Texas, federal court. The suit alleges companies including Blue Cross, Kaiser and Aetna violated RICO and anti-trust laws when conspiring with physician members of the Infectious Diseases Society of America Continues →

CanLyme director responds to Canadian Medical Association Journal article

Response to Doctors Gregson and Quach Robert G. Murray, DDS, Director, CanLyme Re: “The Lyme law” Zubek, 187:520-521doi:10.1503/cmaj.115-0029 The problem with Lyme disease in Canada will only continue to grow to the point where the numbers affected will simply overwhelm the idea that Lyme Borreliosis (LB) is hard to catch and easy to treat with a short round of antibiotics. Continues →

The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease

Abstract Clinical practice guidelines are increasing in number. Unfortunately, when scientific evidence is uncertain, limited, or evolving, as is often the case, conflict often arises between guideline committees and practicing physicians, who bear the direct responsibility for the care of individual patients. The 2006 Infectious Diseases Society of America guidelines for Lyme disease, which have limited scientific support, could, if Continues →

United States : CDC Refuses to End Preferential Treatment of IDSA Lyme Guidelines in Response to Citizen Petition Patient advocates cite CDC/IDSA conflicts of interest

“Fries says, “It’s unacceptable that when a federal government agency is presented with evidence of improprieties, the official response is to confirm the improprieties and indicate they will continue.” Now what will the government of Canada do considering their commitment to open government.  Will they insist Bill C-442 be followed with the good faith intended when enacting the legislation, or Continues →

The Mayday Project Responds to Dr. Paul Auwaerter’s Defense of IDSA Guidelines for Lyme Disease

Friday, November 07, 2014  “My office uncovered undisclosed financial interests held by several of the most powerful IDSA panelists. The IDSA’s guideline panel improperly ignored or minimized consideration of alternative medical opinion and evidence regarding chronic Lyme disease, potentially raising serious questions about whether the recommendations reflected all relevant science.” – Connecticut Attorney General Richard Blumenthal in a May 2008 Continues →

Lyme Warriors Call for Congressional Investigation of CDC, IDSA, Vaccine Makers

ARLINGTON, Va., May 23, 2014  PRNewswire Lyme activists, who have the Infectious Diseases Society of America headquarters surrounded and under siege, issued a call for a Congressional Investigation of corruption within the CDC, IDSA, and the vaccine industry. According to Lyme researcher and activist, Carl Tuttle, “An investigation is long overdue. The conflicts of interest and improper influence among these Continues →

Lyme Disease Community Blows the Whistle on Corruption Within the CDC

[CanLyme note: The Canadian government intentionally takes it’s direction from the US CDC and their small select group to set Lyme policy in Canada.  CanLyme has asked several times to be given a seat at the policy making level only to be told we are simply an advocacy group therefore we have no role to play in decisions that affect Continues →

Infectious Disease Society of America not ethical, or science based… yet Canada openly endorses them while allowing no victim’s expert input.

We all have been duped. Infectious Disease [IDSA] Treatment Guidelines Weakened By Paucity of Scientific Evidence Daniel M. Keller, PhD From: Medscape Today November 13, 2009 (Philadelphia, Pennsylvania)— Two separate analyses presented here at the Infectious Diseases Society of America (IDSA) 47th Annual Meeting revealed that most of the society’s treatment guidelines are based on expert opinion, nonrandomized trials, and case Continues →

Concerns Regarding the Infectious Diseases Society of America Lyme Disease Clinical Practice Guidelines

Reprints or correspondence: Mr. Jim Wilson, Canadian Lyme Disease Foundation, 2495 Reece Rd., Westbank, BC V4T 1N1, Canada (jimwilson@telus.net). TO THE EDITOR — The Canadian Lyme Disease Foundation has several concerns with the Infectious Diseases Society of America’s Lyme disease clinical practice guidelines [1]. I shall elaborate. Throughout the guidelines, the erythema migrans rash is referred to 108 times and Continues →

Chronic Lyme Patients Get Political Victory: New Book by Top Infectious Disease Doctor Supports Long Term Antibiotic Treatment

Chronic Lyme Patients Get Political Victory: New Book by Top Infectious Disease Doctor Supports Long Term Antibiotic Treatment “Chronic Lyme disease does exist,” says Burton A. Waisbren Sr. MD, FACP, FIDSA, in his new book, “Treatment of Chronic Lyme Disease: Fifty-One Case Reports and Essays in Their Regard.” The book, released in January, 2012, adds fuel to the already fiery Continues →